Victory Capital Management Inc. Has $4.57 Million Stock Position in Chemed Co. (NYSE:CHE)

Victory Capital Management Inc. reduced its position in Chemed Co. (NYSE:CHE - Free Report) by 50.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,619 shares of the company's stock after selling 8,798 shares during the quarter. Victory Capital Management Inc. owned approximately 0.06% of Chemed worth $4,566,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. HighTower Advisors LLC raised its holdings in shares of Chemed by 78.0% in the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock worth $2,246,000 after buying an additional 1,634 shares in the last quarter. XTX Topco Ltd lifted its holdings in shares of Chemed by 111.5% during the third quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock valued at $1,709,000 after acquiring an additional 1,499 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Chemed by 4.9% during the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after acquiring an additional 15,791 shares during the period. Signal Advisors Wealth LLC boosted its stake in shares of Chemed by 60.7% in the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock valued at $2,647,000 after purchasing an additional 1,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Chemed by 10.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company's stock worth $72,149,000 after purchasing an additional 13,394 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Remove Ads

Chemed Price Performance

Shares of NYSE:CHE traded down $2.18 during midday trading on Wednesday, reaching $604.12. The company's stock had a trading volume of 36,966 shares, compared to its average volume of 99,711. The business's fifty day simple moving average is $563.45 and its 200-day simple moving average is $565.08. The company has a market capitalization of $8.84 billion, a P/E ratio of 30.52, a P/E/G ratio of 2.15 and a beta of 0.43. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $653.13.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed's dividend payout ratio (DPR) is currently 10.05%.

Analyst Ratings Changes

A number of research firms have commented on CHE. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th.

Insider Activity at Chemed

In other news, VP Brian C. Judkins bought 145 shares of the stock in a transaction dated Monday, December 30th. The stock was bought at an average cost of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company's stock, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.